Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11585 - 11592 of 12011 results
Privacy Class Actions – It’s Still About the Damages
August 18, 2011| Blog| Viewpoint
Second Circuit Analyzes Scope of Material Adverse Employment Actions in a Family Medical Leave Act Retaliation Claim
August 15, 2011| Blog| Viewpoint
NLRB: Broad Confidentiality Clauses May Be Per Se Unlawful
August 12, 2011| Blog| Viewpoint
Sexual Harassment in the Workplace: Not Okay
August 10, 2011| Blog| Viewpoint
The Cat's Paw Just Got a Little Smaller: New York Federal Court Limits Cat's Paw Liability After Staub
August 9, 2011| Blog| Viewpoint
MA Statute Banning Sex Offenders from Living in Nursing Homes without a Hearing is Unconstitutional, Says MA SJC
August 6, 2011| Blog| Viewpoint
Privacy and the Smart Grid: California Public Utilities Commission Adopts Smart Grid Data Protection Rules
August 5, 2011| Blog| Viewpoint
EEOC Sues Taco Bell for Refusing to Accommodate Nazirite's Uncut Hair
July 29, 2011| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|